Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Psych Test 2 > Pharm: Alcohol and Drugs of Abuse > Flashcards

Pharm: Alcohol and Drugs of Abuse Flashcards

1
Q

psychological dependence

A

dependency of the mind - cravings, irritability, insomnia, depression, anorexia

= “addiction”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

sensitization

A

i) An increase in response with repetition of the same dose of the drug (also known as reverse tolerance)
ii) Conditioning is a form of sensitization
iii) The dose-response curve shifts to the left
iv) Example drug: cocaine (repeated daily administration of cocaine to rats produces an increase in motor activity that increases over several days even though the dose remains constant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mesolimbic DA system

A

a) Mesolimbic DA system
i) Prime target of addictive drugs
ii) Originates in the ventral tegmental area (VTA), a tiny structure at the tip of the brainstem, which projects to the nucleus accumbens, the amygdala, the hippocampus, and the prefrontal cortex
iii) Most projections of the VTA are DA-producing neurons: large quantities of DA are released in the nucleus accumbens and the prefrontal cortex when the DA neurons of the VTA are activated
iv) As a general rule, all addictive drugs activate the mesolimbic DA system

Dopamine hypothesis of addiction (DA reward pathway)

i) Dependence-producing drugs activate the mesolimbic DA system, releasing DA
ii) The pleasure-related (hedonic) effect results from activation of this pathway, rather than from a subjective appreciation of the diverse other effects (such as alertness or disinhibition) that the drugs produce

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

LSD

A

nonaddictive DOA - targets cortical and thalamic circuits

i) Lysergic acid diethylamine (LSD), mescaline, psilocybin
(1) Repetitive exposure leads to rapid tolerance (tachyphylaxis)
(2) Animals will not self administer hallucinogens, suggesting they are not addictive in nature

** LSD can cause flashbacks of altered perception years after consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PCP

A

nonaddictive DOA - targets cortical and thalamic circuits

Phencyclidine (PCP) and ketamine

(1) Developed as general anesthetics (ketamine is still used for this purpose)
(2) Club drugs sold under names such as angel dust, Special K, Hog
(3) Psychedelic effects last for about 1 hour and also include increased blood pressure, impaired memory function, disorientation, nystagmus, and visual alterations
(4) Classification of these NMDA antagonist as nonaddictive agents has been questioned due to animal research that shows that PCP can increase mesolimbic dopamine concentrations and has some reinforcing properties in rodents

** PCP may lead to irreversible schizophrenia-like psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

naloxone

A

(i) MOA: pure opioid antagonist that reverses effects of a dose of opiates within minutes
(ii) Provokes an acute withdrawal syndrome in situations where a dependent person has opiates in their system

Withdrawal symptoms include intense dysphoria, nausea or vomiting, muscle aches, lacrimation, rhinorrhea, mydriasis, piloerection, sweating, diarrhea, yawning, fever

NOTE: naloxone is rapid acting, naltrexone is longer onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

methadone

A
  • Long-acting opioids used for substitution therapy (half-life 25-52 hrs) for opioid dependence

Tolerance and physical dependence develop more slowly in comparison to other opioids (e.g., morphine)

Abrupt discontinuation precipitates a withdrawal syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

buprenorphine

A

mixed agonist/antagonist (partial agonist at opioid receptors)

used for opioid dependence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

methadone

A
  • (i) Long-acting opioids used for substitution therapy (half-life 25-52 hrs)
    (ii) Tolerance and physical dependence develop more slowly in comparison to other opioids (e.g., morphine)
    (iii) Given with supervised intake
    (iv) Abrupt discontinuation precipitates a withdrawal syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

opioids

A

GPCR drugs: cause disinhibition of DA neurons
=Drugs that activate Gio-coupled receptors: cause disinhibition of DA neurons

(2) In the VTA, µ opioids cause an inhibition of GABAergic inhibitory interneurons, which leads to a disinhibition of dopamine neurons (see figure below)
(3) µ receptors cause euphoria when activated and are implicated in the reward effects of opiates (commonly abused µ opioids are morphine, heroin, codeine, oxycodone, and meperidine)

Withdrawal symptoms include intense dysphoria, nausea or vomiting, muscle aches, lacrimation, rhinorrhea, mydriasis, piloerection, sweating, diarrhea, yawning, fever

tx for OD: naloxone
tx for substitution therapy: methadone, buprenorphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

buprenorphine

A
  • (i) Long-acting opioids used for substitution therapy (half-life 25-52 hrs)
    (ii) Tolerance and physical dependence develop more slowly in comparison to other opioids (e.g., morphine)
    (iii) Given with supervised intake
    (iv) Abrupt discontinuation precipitates a withdrawal syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cannabinoids

A

GPCR drugs: cause disinhibition of DA neurons

(3) The exogenous cannabinoid Δ9-tetrahydrocannabinol (THC) causes disinhibition of DA neurons by presynaptic inhibition of GABA neurons in the VTA (similar to opioids)
(4) Effects of THC include euphoria, relaxation, feelings of well-being, grandiosity, and altered perception of passage of time
(5) The THC-induced effects of increased appetite, attenuation of nausea, decreased intraocular pressure, and relief of chronic pain have led to the use of cannabinoids in medical therapy
(6) Chronic exposure leads to dependence with a mild and short-lived withdrawal syndrome (includes restlessness, irritability, mild agitation, insomnia, nausea, cramping)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

dronabinol

A

(a) FDA-approved THC analog used for anorexia and weight loss in AIDS patients and cancer-chemotherapy induced nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nabilone

A

(a) THC analog used for the treatment of refractory nausea and vomiting associated with cancer chemotherapy and as an adjunct in chronic pain management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gamma-hydroxybutyric Acid (GHB)

A

GPCR drugs: cause disinhibition of DA neurons

(1) GHB is produced during the metabolism of GABA, but the endogenous function is unknown
(2) Activates the GABAB receptor with low affinity and produces euphoria, enhanced sensory perceptions, feelings of social closeness, and amnesia before causing sedation and coma (originally introduced as a general anesthetic)
(3) Also known as liquid ecstasy or the date rape drug (has been used in date rapes because it is odorless, readily dissolved in beverages, reaches maximal plasma concentration 20-30 minutes after ingestion, and has an elimination half-life of 30 minutes)
(4) Recreational use only inhibits GABA neurons but at higher doses GHB hyperpolarizes DA neurons and inhibits DA release
(5) GHB targets GABAB receptors on both GABA and DA neurons, but those on GABA neurons are more sensitive to GHB and lead to disinhibition of DA neurons when activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

nicotine

A

(a) MOA: selective agonist of the nicotinic acetylcholine receptor (nAChR)
(b) Neuronal nAChRs are expressed on DA neurons in the VTA; activation fulfills the DA requirement of addictive drugs
(c) Though highly addictive, withdrawal is mild compared with opioid withdrawal and involves irritability and sleeplessness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

buproprion

A

(i) Antidepressant with unknown mechanism of action

(ii) Used alone or in combination with nicotine-replacement therapy and/or behavioral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

varenicline

A

“chantix”

(i) Derivative of the plant-extract cytisine
(ii) Partial neuronal nAChR agonist
(iii) Only approved for treating smoking cessation
(iv) Prevents nicotine stimulation of mesolimbic dopamine system associated with nicotine addiction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

cocaine

A
  • MOA:
  • peripheral nervous system, cocaine inhibits voltage-gated sodium channels and can be used as a local anesthetic
  • CNS: Blocks the DAT and increases the DA concentrations in the nucleus accumbens (rewarding effects)
  • CNS: Blocks the NET and activates the sympathetic nervous system, which leads to an acute increase in arterial pressure, tachycardia, ventricular arrhythmias, and pupil dilation

Sx: of use include loss of appetite, hyperactivity, and lack of sleep while overdose may lead to hyperthermia, coma, and death

Caution: !! Exposure increases risk for intracranial hemorrhage, ischemic stroke, myocardial infarction, and seizures !!

Withdrawal syndrome not as strong as that observed with opioids

(7) Reverse tolerance can occur (sensitization to small doses of cocaine)
(8) Susceptible individuals may become dependent and addicted after only a few exposures
(9) No antidote; intoxication management remains supportive with agents to control heart rate/rhythm (β-adrenergic receptor antagonist propranolol) and seizures (sedative-hypnotic diazepam)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

amphetamines

A

(1) MOA: cause the release of endogenous biogenic amines by reversing the action of biogenic amine transporters at the plasma membrane
- Amphetamines are taken up into the cell by the DAT
- Amphetamines block the intracellular VMAT and deplete synaptic vesicles of their neurotransmitter content, which causes levels of DA and other amines (serotonin, norepinephrine) to increase in the cytoplasm
- Increasing levels of amines in the cytoplasm cause the DAT, SERT, and NET to work in reverse and release amines into the synapse!

Amphetamines are neurotoxic (dependent on the NMDA receptor and affects mainly serotonin and DA neurons)

Withdrawal consists of dysphoria, drowsiness (insomnia in some cases), and general irritability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Ecstasy

A

(MDMA; methylenedioxymethamphetamine)

MOA: similar to amphetamines (reverses the action of biogenic amine transporters)

  • Preferential affinity for the SERT and strongly increases the extracellular concentration of serotonin
  • Heavy users of MDMA report long-term cognitive impairment due

Acute toxic effects include hyperthermia, dehydration, serotonin syndrome (mental status change, autonomic hyperactivity, neuromuscular abnormalities), and seizures

Withdrawal consists of a mood “offset” characterized by depression lasting up to several weeks, possible increased aggression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

schedule I

A

The drug or other substance has a high potential for abuse.

The drug or other substance has no currently accepted medical use in treatment in the United States.

There is a lack of accepted safety for use of the drug or other substance under medical supervision.

All research use is illegal under federal law

Examples = heroin, lysergic acid diethylamide (LSD), marijuana, and methaqualone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

schedule III

A

The drug or other substance has less potential for abuse than the drugs or other substances in schedules I and II.

The drug or other substance has a currently accepted medical use in treatment in the United States.

Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.

Prescription must be rewritten after six months or five refills.

Anabolic steroids, codeine and hydrocodone with aspirin or acetaminophen, and some barbiturates are examples of Schedule III substances.

24
Q

schedule IV

A

The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule III.

The drug or other substance has a currently accepted medical use in treatment in the United States.

Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in Schedule III.

Prescription must be rewritten after six months or five refills; differs from Schedule III in penalties for illegal possession.

Examples of drugs included in schedule IV are propoxyphene plus aspirin (Darvon), pentazocine, meprobamate, diazepam, and alprazolam.

25
Q

schedule V

A

The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule IV.

The drug or other substance has a currently accepted medical use in treatment in the United States.

Abuse of the drug or other substances may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in Schedule IV.

As any other nonopioid prescription drug; may also be dispensed without prescription unless additional state regulations apply.

Cough medicines with codeine are examples of Schedule V drugs.

26
Q

PK of ethanol

A

chemistry:
i) Alcohols are amphipathic compounds and have both hydrophilic (polar, water-soluble) and hydrophobic (nonpolar, water-insoluble) portions in their chemical structures
ii) The amphipathic quality of alcohols greatly enhances their ability to cross membranes and increases their extent of absorption and distribution
- EtOH is widely distributed to total body
- Alcohol crosses the blood-brain barrier and its distribution is proportional to total blood flow (concentration rises quickly due to total blood flow to the CNS)

** peak blood levels reached 30 mins after ingestion - absorption occurs through SI

Ethanol undergoes extensive first-pass metabolism by gastric and liver alcohol dehydrogenase (ADH)

27
Q

metabolism of alcohol

A

zero order kinetics

  1. Alcohol dehydrogenase pathway
    * Primary pathway for alcohol metabolism
    - ADH catalyzes the conversion of ethanol to acetaldehyde and is located predominantly in the liver
    - NAD+ is required to convert ethanol to acetaldehyde (this produces NADH, of which excess production may contribute to the metabolic disorders that accompany chronic alcoholism and to the lactic acidosis and hypoglycemia that frequently accompany acute alcohol poisoning)
  2. Acetaldehyde metabolism
    - Mitochondrial NAD+-dependent ALDH catalyzes the reaction of acetaldehyde to acetic acid, which is further metabolized to carbon dioxide and water
    - NAD+ is required to convert acetaldehyde to acetic acid (produces NADH)
    • thus 2 mol of NAD+ are required to convert 1 mol of ethanol to acetic acid (required by both ADH and ALDH)
  • the body is only able to metabolize about 7-10 g of alcohol per hour (zero-order metabolism)
  1. Microsomal ethanol oxidizing system (MEOS)
    - Mixed function oxidases (cytochrome P450s) use NADPH as a cofactor in the metabolism of ethanol to acetaldehyde
    - At higher concentrations of ethanol (when NAD+ is depleted and the alcohol dehydrogenase system becomes saturated) there is increased contribution from the P450s, particularly 2E1, 1A2, and 3A4
    - Chronic alcohol consumption induces MEOS activity (2E1) and can result in the enhanced activation of toxins, free radicals, and hydrogen peroxide
    • Genetic polymorphism of ALDH
  • Some individuals of primarily Asian descent have a low activity level of mitochondrial ALDH
  • When these individuals drink alcohol, they develop high acetaldehyde concentrations and may experience facial flushing, light headedness, palpitations, nausea, and general “hangover” symptoms
  • Appears to protect against alcohol dependence and abuse
  • Individuals with the polymorphism in ALDH who are chronic heavy drinkers and/or alcohol dependent have an increased risk of severe liver disease due to the toxic effects of acetaldehyde
28
Q

fomepizole

A

inhibits ADH and is used in the treatment of acute methanol or ethylene glycol poisoning (see below)

29
Q

aspirin

A

inhibits gastric ADH and can increase ethanol bioavailability

30
Q

levels of alcohol intoxication?

A

ALCOHOL IS A CNS DEPRESSANT!

intoxication = 80 mg/dL = .08% BAC

50-100 = sedation, “high”, slower reaction times

100-200 = impaired motor fn, slurred speech, ataxia

200-300 = emesis, stupor

300-400 = coma

> 500 = resp. depression + death

31
Q

ion channels affected by alcohol?

A

1 - N-methyl-D-aspartate (NMDA) subtype of glutamate receptors

  • Glutamate is the primary excitatory neurotransmitter in the CNS
  • Receptor activation is implicated in many aspects of cognitive function including learning and memory
  • Alcohol inhibits the ability of glutamate to open the cation channel of the NMDA receptor and leads to an increased depression of the CNS
  • *Memory loss that occurs with high levels of alcohol (i.e., blackouts) most likely results from inhibition of NMDA receptor activation
  1. γ-aminobutyric acid (GABA) receptor
    (a) GABA is the primary inhibitory neurotransmitter in the CNS
    (b) Alcohol (like other sedative-hypnotics) enhances the effects of GABA on the GABAA receptor and leads to an increased depression of the CNS

** As concentrations of alcohol increase, individuals experience slurred speech, ataxia, impaired judgment, and disinhibited behavior

32
Q

systemic effects of alcohol?

A
  • respiratory depression d/t CNS depression
  • heart: Depression of myocardial contractility has been observed in individuals who acutely consume moderate amounts of alcohol

smooth mm:

i) Ethanol causes vasodilation, likely due to CNS effects (depression of the vasomotor center) and smooth muscle relaxation caused by the metabolite acetaldehyde
ii) In severe overdose situations, ethanol can cause hypothermia caused by vasodilation
iii) Ethanol causes uterine muscle relaxation and was used intravenously for suppression of premature labor before the introduction of more effective and safe medications (e.g., calcium blockers, magnesium ion, β2-adrenergic receptor agonists)

33
Q

GI effects of chronic alcohol use?

A

esophagus - reflux, barretts, mallory-weiss tears, esophageal cancer

stomach - gastritis

intestines - chronic diarrhea and poor absorption esp. of vitamin B –> can cause osteoporosis and increased brain injuries

pancreas - chronic and acute pancreatitis

liver - leading cause of liver cirrhosis! fatty infiltration!!

34
Q

alcohol w/drawal sx?

A

seizures:
- Expression of NMDA receptors and voltage-sensitive Ca2+ channels are up-regulated, which may underlie the seizures that accompany alcohol withdrawal syndrome
- GABAA receptors are down-regulated, which leads to a continued hyperexcited state of the CNS during withdrawal

toxic psychosis

delirium tremens: delirium, hallucinations, fever, tachycardia

35
Q

Neuro effects of chronic alcohol use?

A
  1. Degenerative changes of the nervous system occur with chronic alcohol abuse and include the following symptoms:
    - Generalized symmetric peripheral nerve injury, which begins with distal parathesias of the hands and feet (most common neurologic abnormality of chronic alcoholics)
    - Gait disturbances and ataxia
    - Dementia and demyelinating disease (rare)
  2. Wernicke-Korsakoff syndrome
    - Paralysis of the external eye muscles, ataxia, and a confused state that can progress to coma and death
    - Associated with thiamine deficiency and rarely seen in the absence of alcoholism
    - Treatment with thiamine will improve ocular problems, ataxia, and confusion, but most patients are left with a chronic disabling memory disorder known as Korsakoff’s psychosis
  3. Painless blurring of vision occurs over several weeks of heavy alcohol consumption, with changes typically bilateral and symmetric (optic nerve degeneration may follow)
36
Q

CV effects of chronic alcohol use?

A
  • cardiomyopathy, ventricular hypertrophy, fibrosis –> heart failure
  • arrhtymias
  • HTN
  • stroke
37
Q

other systemic affects of alcohol use chronically?

A
  • mild anemia d/t folic acid deficiency
  • electrolyte imbalance, gynecomastia and testicular atrophy
  • decreased mm. strength
  • sweating (d/t vasodilation) and internal body temperature falls
  • decreased libido
38
Q

FAS

A

Fetal alcohol syndrome (FAS)

  • Chronic alcohol abuse during pregnancy can have teratogenic effects (apoptotic neurodegeneration)
  • Alcohol is a leading cause of mental retardation and congenital malformation

FAS includes:

(1) Intrauterine growth retardation
(2) Microcephaly
(3) Poor coordination
(4) Underdevelopment of midfacial region
(5) Minor joint abnormalities

Ethanol crosses the placenta and the fetal liver has little or no alcohol dehydrogenase activity and must rely on the mother’s liver for elimination

39
Q

increased risk of what cancers w/ alcohol abuse?

A

increases the risk for cancer of the mouth, pharynx, larynx, esophagus, and liver and may increase the risk of breast cancer in women (though alcohol is not a carcinogen)

Acetaldehyde and reactive oxygen species produced by increased CYP450 activity can damage DNA

40
Q

management of acute alcohol intox?

A

i) Goals include the prevention of severe respiratory depression and aspiration of vomitus
ii) Glucose can treat metabolic alterations such as hypoglycemia and ketosis
iii) Thiamine is provided to protect against the Wernicke-Korsakoff syndrome
iv) Potassium may be required in the event of severe vomiting (if renal function is normal), along with electrolyte solutions

41
Q

management of alcohol w/drawal syndrome?

A
    • Moderate forms of alcohol withdrawal syndrome, characterized by tremor, anxiety, and insomnia, occur 6-8 hours after alcohol consumption is stopped and usually abate in 1-2 days
  • Major pharmacological objective is to prevent seizures, delirium, and arrhythmias and include electrolyte rebalancing and thiamine therapy
    • severe cases = use long-acting sedative-hypnotic drug for alcohol and then gradually tapering the dose
      1. Long-acting benzodiazepines (chlordiazepoxide, clorazepate, diazepam)
  • Benefits: less frequent dosing and built-in tapering effect
  • Disadvantages: pharmacologically active metabolites may accumulate, especially in patients with compromised liver function
    2. Short-acting benzodiazepines (lorazepam, oxazepam)
  • Rapidly converted to inactive metabolites and are useful in patients with liver disease

Tapering of sedative-hypnotic medications can occur over several weeks with complete alcohol detoxification requiring several months of abstinence for restoration of normal CNS function

42
Q

Diazepam

A

use - alcohol w/drawal sx of seizures

Long-acting benzodiazepines (chlordiazepoxide, clorazepate, diazepam)

  • Benefits: less frequent dosing and built-in tapering effect
  • Disadvantages: pharmacologically active metabolites may accumulate, especially in patients with compromised liver function
43
Q

Lorazepam

A

use - alcohol w/drawal sx of seizures

Short-acting benzodiazepines (lorazepam, oxazepam)
- Rapidly converted to inactive metabolites and are useful in patients with liver disease

44
Q

Oxazepam

A

use - alcohol w/drawal sx of seizures

Short-acting benzodiazepines (lorazepam, oxazepam)
- Rapidly converted to inactive metabolites and are useful in patients with liver disease

45
Q

Naltrexone

A

** Approved for the treatment of alcohol and opiate dependence

MOA: µ opioid receptor antagonist (long-acting)
- Reduces the craving for alcohol and the rate of relapse to either drinking or alcohol dependence for the short term (12 weeks)

CI: in patients with acute hepatitis or liver failure
- Causes dose-related hepatocellular injury; avoid combination of naltrexone and disulfiram (also hepatotoxic)

46
Q

Acamprosate

A

MOA: weak NMDA-receptor antagonist and GABA¬A receptor agonist (also affects serotonergic, noradrenergic, and dopaminergic systems)

Reduces short-term and long-term (more than 6 months) relapse rates when combined with psychotherapy

** caution in patients with kidney disease

AE: nausea, vomiting, diarrhea, and rash

Can be used in combination with naltrexone or disulfiram

47
Q

Disulfiram

A
  • MOA: irreversibly inhibits aldehyde dehydrogenase and causes extreme discomfort in patients who drink alcoholic beverages (flushing, throbbing headache, nausea, vomiting, sweating, hypotension, confusion due to the accumulation of aldehyde)
  • effects start within minutes of alcohol consumption and last 30 minutes to several hours; effects may occur when alcohol is consumed up to 14 days after a previous dose
  • Hepatotoxic and inhibits the metabolism of other therapeutic agents (phenytoin, oral anticoagulants, isoniazid, caffeine, barbiturates)

** Not a cure for alcohol dependence and must be used in patients who are highly motivated and have supportive therapy

**Not commonly used due to low compliance; evidence from clinical trials for its effectiveness is weak

48
Q

Naltrexone

A

(1) Approved for the treatment of alcohol and opiate dependence
(2) MOA: µ opioid receptor antagonist (long-acting)
(3) Reduces the craving for alcohol and the rate of relapse to either drinking or alcohol dependence for the short term (12 weeks)
(4) Extensive first-pass metabolism; contraindicated in patients with acute hepatitis or liver failure
(5) Causes dose-related hepatocellular injury; avoid combination of naltrexone and disulfiram (also hepatotoxic)

49
Q

ehtylene glycol ingestion

A
  • Accidental overdose in pets and children due to the sweet taste of ethylene glycol in antifreeze (also in heat exchangers and industrial solvents)
  • Metabolized to toxic aldehydes and oxalate

Treatment:

(1) Hemodialysis
(2) Ethanol infusion
(3) Fomepizole

50
Q

Acamprosate

A

(1) MOA: weak NMDA-receptor antagonist and GABA¬A receptor agonist (also affects serotonergic, noradrenergic, and dopaminergic systems)
(2) Reduces short-term and long-term (more than 6 months) relapse rates when combined with psychotherapy
(3) Eliminated in urine as an uncharged drug; use caution in patients with kidney disease
(4) Most common adverse effects are nausea, vomiting, diarrhea, and rash
(5) Can be used in combination with naltrexone or disulfiram

51
Q

methanol

A
  • Poisonings can occur from accidental ingestion of methanol-containing products or when it is used by alcoholics as an ethanol substitute

** Most common characteristic symptom in methanol poisoning is blurred vision (“like being in a snowstorm”)

Treatment:

(1) Respiratory support
(2) Suppression of metabolism by ADH (ethanol and fomepizole)
(3) Hemodialysis to enhance methanol removal
(4) Alkalinization to counteract metabolic acidosis (bicarbonate)
* * Ethanol has a higher affinity than methanol for ADH and is often used intravenously as treatment for methanol poisoning

Fomepizole inhibits ADH and is approved for the treatment of methanol poisoning

52
Q

ehtylene glycol ingestion

A
  • Accidental overdose in pets and children due to the sweet taste of ethylene glycol in antifreeze (also in heat exchangers and industrial solvents)
  • Metabolized to toxic aldehydes and oxalate

Treatment:

(1) Hemodialysis
(2) Ethanol infusion
(3) Fomepizole

53
Q

which receptors does EtOH target?

A

Ionotropic receptors:

  1. N-methyl-D-aspartate (NMDA) glutamate receptors
    - Cation channel (Na+ and Ca2+)
    - Glutamate is the primary excitatory neurotransmitter in the CNS (memory)
    - Alcohol inhibits NMDA receptor channel opening
  2. GABAA receptors
    - Anion channel (Cl-)
    - GABA is the primary inhibitory neurotransmitter in the CNS
    - Alcohol enhances GABA’s effects on the GABAA receptor

decreased NMDA function, increased GABAa function!

54
Q

how do drugs that activate GPCR work?

A

Opioids, cannabinoids, GHB

Inhibiting Ca2+ influx and increasing outflow of K+ decreases the likelihood of an action potential and GABA release

Blocks the inhibitory effects of GABAergic neurons

Dopamine levels are increased because of dopamine neuron disinhibition

55
Q

which drugs bind ionotorpic receptors?

A

Nicotine, alcohol, benzodiazepines, barbiturates, phencyclidine, ketamine

Psych Test 2 (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions